Intersect ENT Announces Launch of the New Straight Delivery System Packaged with the PROPEL Mini Sinus Implant
MENLO PARK, CA -- Intersect ENT®, Inc. (Nasdaq: XENT), a global ear, nose and throat (“ENT”) medical technology leader dedicated to transforming patient care, today announced the U.S. availability of the new Straight Delivery System (“SDS”) packaged with the company’s PROPEL® Mini (mometasone furoate) Sinus Implant. The combined packaging of the SDS with PROPEL Mini received premarket approval (“PMA”) by the U.S. Food and Drug Administration (“FDA”) which follows PMA for the Straight Delivery System received in July 2020.
The Straight Delivery System is an extension of the PROPEL family of implants. It is specifically engineered for precise, consistent and easy delivery of the PROPEL Mini implant into the ethmoid sinus for maximum tissue apposition. The original curved delivery system will continue to be available with the PROPEL Mini sinus implant, offering physicians a suite of options when using PROPEL Mini following sinus surgery.
“Intersect ENT is pleased to provide our physicians with a complete package of PROPEL Mini and the Straight Delivery System,” commented Thomas A. West, President and CEO of Intersect ENT. “We are dedicated to responding to our customers’ feedback and providing them with the best combination of products to advance care for chronic sinusitis patients in various centers of care.”
“The combination of the PROPEL Mini and the Straight Delivery System in one package is reflective of Intersect ENT’s ongoing commitment to supporting the ENT community,” states Roheen Raithatha, MD, practicing Rhinologist at ENT and Allergy Associates and faculty member at Mt Sinai Hospital in New York. “I look forward to utilizing this newly bundled implant and delivery system during my FESS procedures.”
-
Most popular related searches
Related products
PROPEL - Sinus Implants
Related news
-
Olansi air purifier review : Can Olansi Air Purifiers Help Avoid Allergies?
This is one of the most questions about air purifiers. Most people wonder if AP air purifiers can help them with allergies. In this article, we are going to talk about this question. The short answer is, yes these units can help avoid allergies caused by dust, dander, and pet hair. Read on to find out. First of all, we should talk about the most common household allergens that can be found in almost every home. Pet Fur Pet fur is one of the most common allergens. In fact, since these allergies are quite...
-
Indee Labs Awarded Grant from the National Institute of Allergy & Infectious Disease
Indee Labs is a biotechnology company developing the µVS Delivery SystemTM for non-viral intracellular or gene delivery. The team at Indee Labs was awarded a grant from the National Institute of Allergy and Infectious Diseases (NIAID), part of the National Institutes of Health (NIH), to develop the µVS Delivery SystemTM for modified regulatory T cells. “Cellular immunotherapies using regulatory T cells (Tregs) show tremendous promise for the treatment of autoimmune disease, transplant rejection,...
-
Bio-Me represented with two presentations at the 6th Microbiome Movement – Drug Development Summit 2021
On July 1st Bio-Me has two back-to-back presentations. Our Founder and CEO, Morten L. Isaksen will first be presenting how we support companies in their development of microbiome modulating drugs with our PMP™ technology for targeted microbiome analysis. Following that, our COO Warren Flood will do a joint presentation with Ricardo Valladares, CSO at Siolta Therapeutics showcasing how we work together to facilitate their drug development in infant allergic disease. For more information about the collaboration...
-
Asthma and Allergy Awareness Month in Puerto Rico and Identifying Environmental Asthma Triggers
The month of May is recognized as Asthma and Allergy Awareness Month in Puerto Rico and across the globe. World Asthma Day also occurs on the 5th of May. These times of recognition are important as asthma is a chronic lung disease that has a major impact on the lives of too many residents of Puerto Rico. In fact, the U.S. Department of Health and Human Services reports that Puerto Rican children are three times as likely to have asthma, as compared to non-Hispanic whites. A recent study by researchers from the...
-
Lyra Therapeutics Reports Fourth Quarter and Full Year 2020 Financial Results, Provides Corporate Update
Lyra Therapeutics, Inc. (Nasdaq: LYRA), a clinical-stage therapeutics company focused on the development and commercialization of novel integrated drug and delivery solutions for the localized treatment of patients with ear, nose and throat (ENT) diseases, today reported financial results for the fourth quarter and full year ended December 31, 2020 and provided a corporate update. Key Fourth Quarter 2020 and Subsequent Highlights Company Announced Positive Topline Results for LANTERN Phase 2 Study of LYR-210....
Customer comments
No comments were found for Intersect ENT Announces Launch of the New Straight Delivery System Packaged with the PROPEL Mini Sinus Implant. Be the first to comment!